TSHA Taysha Gene Therapies | $2.97
-26.3% | 6/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 6/18/2024 |
RNA Avidity Biosciences | $38.33
-3.2% | 6/12/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $33.00 -> $45.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 6/12/2024 |
OBIO Orchestra BioMed | $7.44
-7.5% | 6/12/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 -> $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 6/12/2024 |
OCS Oculis | $11.75
| 6/11/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $30.00 -> $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 6/11/2024 |
CGTX Cognition Therapeutics | $2.01
-8.2% | 6/6/2024 | Initiated by | Chardan Capital | Analyst D. Gataulin | Buy | $11.00 | Low | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 6/6/2024 |
COYA Coya Therapeutics | $6.49
-4.0% | 6/5/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/5/2024 |
|
ABUS Arbutus Biopharma | $3.01
-1.6% | 6/5/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 6/5/2024 |
IBIO iBio | $2.30
| 6/3/2024 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of iBio (NYSE:IBIO) on 6/3/2024 |
ARWR Arrowhead Pharmaceuticals | $23.58
-6.1% | 6/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/3/2024 |
NVX NOVONIX | $1.71
-1.2% | 5/30/2024 | Initiated by | Chardan Capital | Analyst B. Dobson | Buy | $4.00 | Low | View details for Chardan Capital rating of NOVONIX (NASDAQ:NVX) on 5/30/2024 |
IBIO iBio | $2.30
| 5/28/2024 | Initiated by | Chardan Capital | Analyst K. Nakae | Buy | $5.00 | Low | View details for Chardan Capital rating of iBio (NYSE:IBIO) on 5/28/2024 |
CRGO Freightos | $2.19
+2.3% | 5/23/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $8.00 -> $6.00 | Low | View details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 5/23/2024 |
SABS SAB Biotherapeutics | $2.58
-20.6% | 5/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 -> $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/21/2024 |
DYN Dyne Therapeutics | $33.15
+4.3% | 5/21/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $31.00 -> $42.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/21/2024 |
BMTX BM Technologies | $2.53
-8.3% | 5/20/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 5/20/2024 |
SLN Silence Therapeutics | $18.90
-0.5% | 5/17/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $42.00 -> $42.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 5/17/2024 |
ALUR Allurion Technologies | $1.08
-3.6% | 5/15/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 5/15/2024 |
OCGN Ocugen | $1.38
+3.0% | 5/15/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/15/2024 |
CLSK CleanSpark | $19.48
+1.2% | 5/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/13/2024 |
RNA Avidity Biosciences | $38.33
-3.2% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $33.00 -> $33.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 5/10/2024 |
PRQR ProQR Therapeutics | $1.67
-1.8% | 5/10/2024 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $2.50 -> $2.50 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 5/10/2024 |
ARWR Arrowhead Pharmaceuticals | $23.58
-6.1% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/10/2024 |
PET Wag! Group | $1.44
-4.6% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 5/10/2024 |
COYA Coya Therapeutics | $6.49
-4.0% | 5/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 5/9/2024 |
VLN Valens Semiconductor | $3.10
-0.3% | 5/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/9/2024 |
SLDP Solid Power | $1.59
-4.8% | 5/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 5/8/2024 |
MCRB Seres Therapeutics | $0.71
+6.0% | 5/8/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $8.00 -> $6.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 5/8/2024 |
PLBY PLBY Group | $0.75
-5.1% | 5/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 5/8/2024 |
MARA Marathon Digital | $20.28
+1.3% | 5/8/2024 | Target Lowered by | Chardan Capital | - | Neutral -> Neutral | $30.00 -> $21.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 5/8/2024 |
CLSK CleanSpark | $19.48
+1.2% | 5/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/7/2024 |
OMGA Omega Therapeutics | $2.22
+19.4% | 5/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 5/7/2024 |
EYPT EyePoint Pharmaceuticals | $8.69
-3.6% | 5/7/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $39.00 -> $28.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/7/2024 |
DYN Dyne Therapeutics | $33.15
+4.3% | 5/6/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $31.00 -> $31.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024 |
ABUS Arbutus Biopharma | $3.01
-1.6% | 5/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 5/3/2024 |
ALNY Alnylam Pharmaceuticals | $153.86
-2.2% | 5/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $225.00 -> $225.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/3/2024 |
COYA Coya Therapeutics | $6.49
-4.0% | 4/29/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/29/2024 |
BMTX BM Technologies | $2.53
-8.3% | 4/22/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/22/2024 |
OCGN Ocugen | $1.38
+3.0% | 4/22/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $4.00 -> $5.00 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/22/2024 |
PRME Prime Medicine | $6.28
-1.1% | 4/22/2024 | Initiated by | Chardan Capital | - | Buy | $17.00 | Low | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 4/22/2024 |
LICY Li-Cycle | $5.49
+18.3% | 4/19/2024 | Reiterated by | Chardan Capital | - | Neutral -> Neutral | $6.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 4/19/2024 |
Historic NVIDIA partnership could send this tiny AI stock soaring... (Ad) After striking partnerships with trillion-dollar chipmaker NVIDIA...
ARM surged over 60% in a week... Who's next? Click here to discover the name and ticker symbol >>> |
DFLI Dragonfly Energy | $0.86
-1.2% | 4/16/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $3.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 4/16/2024 |
SABS SAB Biotherapeutics | $2.58
-20.6% | 4/16/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024 |
NRGV Energy Vault | $1.05
-0.9% | 4/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Sell | $7.00 -> $0.75 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 4/8/2024 |
ACHL Achilles Therapeutics | $0.89
-1.1% | 4/5/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $11.00 -> $6.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 4/5/2024 |
BMTX BM Technologies | $2.53
-8.3% | 4/4/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/4/2024 |
ALUR Allurion Technologies | $1.08
-3.6% | 4/4/2024 | Initiated by | Chardan Capital | - | Buy | $5.00 | Low | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 4/4/2024 |
OUST Ouster | $10.68
-2.1% | 4/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Neutral | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 4/3/2024 |
SABS SAB Biotherapeutics | $2.58
-20.6% | 4/2/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $3.00 -> $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/2/2024 |
FEMY Femasys | $0.96
-5.9% | 4/1/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 4/1/2024 |
OMGA Omega Therapeutics | $2.22
+19.4% | 4/1/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $12.00 -> $7.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 4/1/2024 |
OBIO Orchestra BioMed | $7.44
-7.5% | 3/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/28/2024 |
MGX Metagenomi | $3.88
-7.8% | 3/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $21.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/28/2024 |
GANX Gain Therapeutics | $1.28
-3.0% | 3/27/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2024 |
PLBY PLBY Group | $0.75
-5.1% | 3/26/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 3/26/2024 |
TNYA Tenaya Therapeutics | $3.16
-4.2% | 3/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/21/2024 |
FEMY Femasys | $0.96
-5.9% | 3/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/21/2024 |
TSHA Taysha Gene Therapies | $2.97
-26.3% | 3/21/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $5.00 -> $7.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/21/2024 |
COYA Coya Therapeutics | $6.49
-4.0% | 3/20/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $11.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/20/2024 |
OCS Oculis | $11.75
| 3/19/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 3/19/2024 |
ADVM Adverum Biotechnologies | $6.59
-10.0% | 3/19/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 3/19/2024 |
PRQR ProQR Therapeutics | $1.67
-1.8% | 3/14/2024 | Target Raised by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $2.00 -> $2.50 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2024 |
SLN Silence Therapeutics | $18.90
-0.5% | 3/14/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $26.00 -> $42.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/14/2024 |
IMRX Immuneering | $1.48
-3.3% | 3/15/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $21.00 -> $16.00 | N/A | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/15/2024 |
GWH ESS Tech | $0.73
-3.9% | 3/15/2024 | Target Lowered by | Chardan Capital | - | Neutral -> Neutral | $1.90 -> $0.80 | N/A | View details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/15/2024 |
NRGV Energy Vault | $1.05
-0.9% | 3/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/18/2024 |
DYN Dyne Therapeutics | $33.15
+4.3% | 3/8/2024 | Target Raised by | Chardan Capital | - | Buy | $20.00 -> $31.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/8/2024 |
RGNX REGENXBIO | $12.21
+4.9% | 3/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $52.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/7/2024 |
MCRB Seres Therapeutics | $0.71
+6.0% | 3/6/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
MGX Metagenomi | $3.88
-7.8% | 3/5/2024 | Initiated by | Chardan Capital | - | Buy | $21.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/5/2024 |
MARA Marathon Digital | $20.28
+1.3% | 3/4/2024 | Target Raised by | Chardan Capital | - | Neutral -> Neutral | $26.00 -> $30.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 3/4/2024 |
CLSK CleanSpark | $19.48
+1.2% | 3/4/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $13.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 3/4/2024 |
ABUS Arbutus Biopharma | $3.01
-1.6% | 3/1/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/1/2024 |
RNA Avidity Biosciences | $38.33
-3.2% | 2/29/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 2/29/2024 |
SLDP Solid Power | $1.59
-4.8% | 2/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | Low | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 2/28/2024 |
CRSP CRISPR Therapeutics | $60.57
-2.0% | 2/22/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $110.00 -> $112.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2024 |
IOVA Iovance Biotherapeutics | $8.00
-1.0% | 2/20/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $29.00 -> $34.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/20/2024 |
ALNY Alnylam Pharmaceuticals | $153.86
-2.2% | 2/16/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $250.00 -> $225.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/16/2024 |
OTLK Outlook Therapeutics | $7.07
-6.5% | 2/15/2024 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $60.00 | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/15/2024 |
SYBX Synlogic | $1.59
| 2/9/2024 | Downgraded by | Chardan Capital | Analyst K. Nakae | Buy -> Neutral | | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 2/9/2024 |
OCS Oculis | $11.75
| 12/5/2023 | Initiated by | Chardan Capital | Analyst D. Gataulin | Buy | $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 12/5/2023 |
LXEO Lexeo Therapeutics | $15.64
-3.8% | 11/28/2023 | Initiated by | Chardan Capital | Analyst G. Livshits | Buy | $23.00 | Low | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023 |
LICY Li-Cycle | $5.49
+18.3% | 11/16/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 11/16/2023 |
PRQR ProQR Therapeutics | $1.67
-1.8% | 11/8/2023 | Upgraded by | Chardan Capital | Analyst K. Nakae | Neutral -> Buy | $2.00 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 11/8/2023 |
WBX Wallbox | $1.31
-1.5% | 10/19/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $2.25 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 10/19/2023 |
VYGR Voyager Therapeutics | $8.16
-1.2% | 9/18/2023 | Reiterated by | Chardan Capital | Analyst G. Livshits | Neutral | | Low | View details for Chardan Capital rating of Voyager Therapeutics (NASDAQ:VYGR) on 9/18/2023 |
OTLK Outlook Therapeutics | $7.07
-6.5% | 8/31/2023 | Downgraded by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/31/2023 |
ZURA Zura Bio | $3.38
-9.4% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy | | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 8/17/2023 |
QURE uniQure | $4.57
-2.6% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst Y. Livshits | Buy | | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 8/17/2023 |
PPBT Purple Biotech | $0.53
-1.9% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy | | Low | View details for Chardan Capital rating of Purple Biotech (NASDAQ:PPBT) on 8/17/2023 |
PLBY PLBY Group | $0.75
-5.1% | 8/17/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 8/17/2023 |
Historic NVIDIA partnership could send this tiny AI stock soaring... (Ad) After striking partnerships with trillion-dollar chipmaker NVIDIA...
ARM surged over 60% in a week... Who's next? Click here to discover the name and ticker symbol >>> |
SLN Silence Therapeutics | $18.90
-0.5% | 8/17/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/17/2023 |
IOVA Iovance Biotherapeutics | $8.00
-1.0% | 8/16/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/16/2023 |
LICY Li-Cycle | $5.49
+18.3% | 8/16/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $64.00 -> $56.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/16/2023 |
VLN Valens Semiconductor | $3.10
-0.3% | 8/15/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $9.00 -> $5.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 8/15/2023 |
SNTI Senti Biosciences | $0.25
+4.2% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 8/15/2023 |
OTLK Outlook Therapeutics | $7.07
-6.5% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $200.00 | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/15/2023 |
TSHA Taysha Gene Therapies | $2.97
-26.3% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/15/2023 |
TNYA Tenaya Therapeutics | $3.16
-4.2% | 8/14/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/14/2023 |
GANX Gain Therapeutics | $1.28
-3.0% | 8/14/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 8/14/2023 |
SYBX Synlogic | $1.59
| 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $90.00 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 8/11/2023 |
CLSK CleanSpark | $19.48
+1.2% | 8/11/2023 | Target Raised by | Chardan Capital | - | Buy -> Buy | $10.00 -> $11.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 8/11/2023 |
MGTX MeiraGTx | $4.27
-2.7% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $41.00 | Low | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 8/11/2023 |
FDMT 4D Molecular Therapeutics | $22.78
-4.3% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $31.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/11/2023 |
RCKT Rocket Pharmaceuticals | $20.68
-2.5% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $61.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2023 |
FEMY Femasys | $0.96
-5.9% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $10.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 8/11/2023 |
ADVM Adverum Biotechnologies | $6.59
-10.0% | 8/11/2023 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $20.00 -> $40.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 8/11/2023 |
OBIO Orchestra BioMed | $7.44
-7.5% | 8/9/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/9/2023 |
COYA Coya Therapeutics | $6.49
-4.0% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $11.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/9/2023 |
NRGV Energy Vault | $1.05
-0.9% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/9/2023 |
IOVA Iovance Biotherapeutics | $8.00
-1.0% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/9/2023 |
PET Wag! Group | $1.44
-4.6% | 8/10/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 | N/A | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 8/10/2023 |
SLDP Solid Power | $1.59
-4.8% | 8/10/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | N/A | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 8/10/2023 |
IPSC Century Therapeutics | $2.97
-5.7% | 8/9/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $19.00 -> $17.00 | Low | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 8/9/2023 |
RNA Avidity Biosciences | $38.33
-3.2% | 8/9/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $27.00 -> $23.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/9/2023 |
ARWR Arrowhead Pharmaceuticals | $23.58
-6.1% | 8/8/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/8/2023 |
ALNY Alnylam Pharmaceuticals | $153.86
-2.2% | 8/8/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $250.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 8/8/2023 |
CRSP CRISPR Therapeutics | $60.57
-2.0% | 8/7/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $123.00 -> $110.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/7/2023 |
KRYS Krystal Biotech | $173.00
-2.7% | 8/7/2023 | Target Raised by | Chardan Capital | - | Buy -> Buy | $148.00 -> $153.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/7/2023 |
PASG Passage Bio | $0.96
-5.9% | 8/7/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 8/7/2023 |
MARA Marathon Digital | $20.28
+1.3% | 8/7/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $15.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 8/7/2023 |
NTLA Intellia Therapeutics | $24.80
-1.5% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $107.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/7/2023 |
ACHL Achilles Therapeutics | $0.89
-1.1% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $11.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 8/7/2023 |
IMRX Immuneering | $1.48
-3.3% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $22.00 | Low | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/7/2023 |
ABUS Arbutus Biopharma | $3.01
-1.6% | 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 8/4/2023 |
DYN Dyne Therapeutics | $33.15
+4.3% | 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 8/4/2023 |
OMGA Omega Therapeutics | $2.22
+19.4% | 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 8/4/2023 |
PRQR ProQR Therapeutics | $1.67
-1.8% | 8/4/2023 | Reiterated by | Chardan Capital | - | Neutral -> Neutral | $2.00 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 8/4/2023 |
MESO Mesoblast | $7.49
+3.5% | 8/4/2023 | Target Lowered by | Chardan Capital | - | Sell -> Sell | $4.00 -> $3.00 | Low | View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 8/4/2023 |
RGNX REGENXBIO | $12.21
+4.9% | 8/3/2023 | Reiterated by | Chardan Capital | - | Buy | $55.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 8/3/2023 |
EYPT EyePoint Pharmaceuticals | $8.69
-3.6% | 8/3/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $22.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 8/3/2023 |
EDIT Editas Medicine | $5.04
-0.6% | 8/2/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $22.00 -> $19.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 8/2/2023 |
NRGV Energy Vault | $1.05
-0.9% | 8/2/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/2/2023 |
LICY Li-Cycle | $5.49
+18.3% | 8/1/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $64.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/1/2023 |
BMTX BM Technologies | $2.53
-8.3% | 7/26/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 7/26/2023 |
KOD Kodiak Sciences | $2.61
-3.0% | 7/25/2023 | Downgraded by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | Low | View details for Chardan Capital rating of Kodiak Sciences (NASDAQ:KOD) on 7/25/2023 |
CLSK CleanSpark | $19.48
+1.2% | 7/24/2023 | Target Raised by | Chardan Capital | - | Buy | $6.00 -> $10.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 7/24/2023 |
FBRX Forte Biosciences | $0.54
+3.9% | 7/16/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Neutral | | Low | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 7/16/2023 |
DFLI Dragonfly Energy | $0.86
-1.2% | 7/13/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $10.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 7/13/2023 |
OUST Ouster | $10.68
-2.1% | 7/13/2023 | Upgraded by | Chardan Capital | - | Neutral -> Buy | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 7/13/2023 |
WBX Wallbox | $1.31
-1.5% | 6/30/2023 | Target Lowered by | Chardan Capital | - | Buy | $12.00 -> $11.00 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 6/30/2023 |
Historic NVIDIA partnership could send this tiny AI stock soaring... (Ad) After striking partnerships with trillion-dollar chipmaker NVIDIA...
ARM surged over 60% in a week... Who's next? Click here to discover the name and ticker symbol >>> |
ZURA Zura Bio | $3.38
-9.4% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 7/10/2023 |
XLO Xilio Therapeutics | $0.95
| 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 7/10/2023 |
QURE uniQure | $4.57
-2.6% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 7/10/2023 |
PPBT Purple Biotech | $0.53
-1.9% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Purple Biotech (NASDAQ:PPBT) on 7/10/2023 |
IMVT Immunovant | $26.19
-2.3% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 7/10/2023 |
IMNM Immunome | $13.28
+1.0% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 7/10/2023 |
FDMT 4D Molecular Therapeutics | $22.78
-4.3% | 7/11/2023 | Target Raised by | Chardan Capital | - | | $30.00 -> $31.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/11/2023 |
FDMT 4D Molecular Therapeutics | $22.78
-4.3% | 7/5/2023 | Initiated by | Chardan Capital | - | Buy | $30.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/5/2023 |
ZURA Zura Bio | $3.38
-9.4% | 6/14/2023 | Initiated by | Chardan Capital | Analyst M. Barcus | Buy | $14.00 | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 6/14/2023 |
NTLA Intellia Therapeutics | $24.80
-1.5% | 6/13/2023 | Target Lowered by | Chardan Capital | - | | $111.00 -> $107.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/13/2023 |
COYA Coya Therapeutics | $6.49
-4.0% | 6/7/2023 | Target Raised by | Chardan Capital | Analyst K. Nakae | | $9.00 -> $11.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/7/2023 |
SYBX Synlogic | $1.59
| 6/6/2023 | Target Raised by | Chardan Capital | - | | $82.50 -> $90.00 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 6/6/2023 |
MESO Mesoblast | $7.49
+3.5% | 5/30/2023 | Target Lowered by | Chardan Capital | - | | $5.00 -> $4.00 | Low | View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 5/30/2023 |
IMVT Immunovant | $26.19
-2.3% | 5/22/2023 | Target Raised by | Chardan Capital | - | | $21.00 -> $32.00 | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 5/22/2023 |
KRYS Krystal Biotech | $173.00
-2.7% | 5/22/2023 | Target Raised by | Chardan Capital | - | | $133.00 -> $148.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 5/22/2023 |
EYPT EyePoint Pharmaceuticals | $8.69
-3.6% | 5/18/2023 | Target Raised by | Chardan Capital | - | | $21.00 -> $22.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/18/2023 |
FBRX Forte Biosciences | $0.54
+3.9% | 5/15/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Neutral | | Low | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 5/15/2023 |
TNYA Tenaya Therapeutics | $3.16
-4.2% | 5/11/2023 | Target Lowered by | Chardan Capital | - | | $24.00 -> $23.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 5/11/2023 |
VLN Valens Semiconductor | $3.10
-0.3% | 5/11/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $12.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/11/2023 |
QURE uniQure | $4.57
-2.6% | 5/10/2023 | Target Lowered by | Chardan Capital | - | | $60.00 -> $56.00 | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/10/2023 |
OCGN Ocugen | $1.38
+3.0% | 5/7/2023 | Target Raised by | Chardan Capital | Analyst D. Gataulin | | $3.50 -> $4.00 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/7/2023 |
RCKT Rocket Pharmaceuticals | $20.68
-2.5% | 5/5/2023 | Target Lowered by | Chardan Capital | - | | $63.00 -> $61.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/5/2023 |
RGNX REGENXBIO | $12.21
+4.9% | 5/4/2023 | Target Lowered by | Chardan Capital | - | | $61.00 -> $55.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 5/4/2023 |
MCRB Seres Therapeutics | $0.71
+6.0% | 4/28/2023 | Target Lowered by | Chardan Capital | - | | $12.00 -> $10.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 4/28/2023 |
WBX Wallbox | $1.31
-1.5% | 4/18/2023 | Reiterated by | Chardan Capital | - | Buy | $12.00 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 4/18/2023 |
IMRX Immuneering | $1.48
-3.3% | 4/18/2023 | Target Raised by | Chardan Capital | - | Buy | $18.00 -> $22.00 | Low | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 4/18/2023 |
OCGN Ocugen | $1.38
+3.0% | 4/14/2023 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy | $3.50 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/14/2023 |
CLSK CleanSpark | $19.48
+1.2% | 4/17/2023 | Reiterated by | Chardan Capital | - | Buy | $5.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 4/17/2023 |
MARA Marathon Digital | $20.28
+1.3% | 4/3/2023 | Reiterated by | Chardan Capital | - | Buy | $15.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 4/3/2023 |
COYA Coya Therapeutics | $6.49
-4.0% | 3/30/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy | $9.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/30/2023 |
RNA Avidity Biosciences | $38.33
-3.2% | 3/31/2023 | Reiterated by | Chardan Capital | - | Buy | $27.00 | N/A | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/31/2023 |
FEMY Femasys | $0.96
-5.9% | 3/30/2023 | Target Lowered by | Chardan Capital | - | Buy | $12.00 -> $10.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/30/2023 |
TSHA Taysha Gene Therapies | $2.97
-26.3% | 3/29/2023 | Target Lowered by | Chardan Capital | - | Buy | $6.00 -> $5.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/29/2023 |
SYBX Synlogic | $1.59
| 3/29/2023 | Target Lowered by | Chardan Capital | - | Buy | $105.00 -> $82.50 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 3/29/2023 |
MARA Marathon Digital | $20.28
+1.3% | 3/28/2023 | Target Lowered by | Chardan Capital | - | Buy | $17.00 -> $15.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 3/28/2023 |
BMTX BM Technologies | $2.53
-8.3% | 3/29/2023 | Reiterated by | Chardan Capital | - | Buy | $13.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 3/29/2023 |
GANX Gain Therapeutics | $1.28
-3.0% | 3/27/2023 | Target Raised by | Chardan Capital | - | | $4.00 -> $5.75 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2023 |
OUST Ouster | $10.68
-2.1% | 3/24/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 3/24/2023 |
SNTI Senti Biosciences | $0.25
+4.2% | 3/23/2023 | Target Lowered by | Chardan Capital | - | Buy | $8.00 -> $7.00 | Low | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 3/23/2023 |
IMTX Immatics | $12.58
-3.3% | 3/23/2023 | Target Lowered by | Chardan Capital | - | Buy | $28.00 -> $25.00 | Low | View details for Chardan Capital rating of Immatics (NASDAQ:IMTX) on 3/23/2023 |
COYA Coya Therapeutics | $6.49
-4.0% | 3/22/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy | $9.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/22/2023 |
ANIX Anixa Biosciences | $2.47
-5.0% | 3/22/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | $8.00 -> $9.00 | Low | View details for Chardan Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/22/2023 |
CABA Cabaletta Bio | $8.35
-10.8% | 3/22/2023 | Reiterated by | Chardan Capital | - | Buy | $12.00 | Low | View details for Chardan Capital rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2023 |
IPSC Century Therapeutics | $2.97
-5.7% | 3/22/2023 | Reiterated by | Chardan Capital | Analyst G. Livshits | Buy | $19.00 | Low | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 3/22/2023 |
IMNM Immunome | $13.28
+1.0% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $9.00 -> $8.00 | Low | View details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 3/16/2023 |
CRGO Freightos | $2.19
+2.3% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $11.00 | Low | View details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 3/16/2023 |
MGTX MeiraGTx | $4.27
-2.7% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $47.00 -> $41.00 | Low | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 3/16/2023 |
SLN Silence Therapeutics | $18.90
-0.5% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $29.00 -> $26.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/16/2023 |
NRGV Energy Vault | $1.05
-0.9% | 3/9/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/9/2023 |
TNYA Tenaya Therapeutics | $3.16
-4.2% | 3/9/2023 | Target Lowered by | Chardan Capital | - | Buy | $28.00 -> $24.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/9/2023 |
Historic NVIDIA partnership could send this tiny AI stock soaring... (Ad) After striking partnerships with trillion-dollar chipmaker NVIDIA...
ARM surged over 60% in a week... Who's next? Click here to discover the name and ticker symbol >>> |
MCRB Seres Therapeutics | $0.71
+6.0% | 3/8/2023 | Reiterated by | Chardan Capital | - | Buy | $12.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/8/2023 |
ACHL Achilles Therapeutics | $0.89
-1.1% | 3/8/2023 | Target Lowered by | Chardan Capital | - | | $17.00 -> $12.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 3/8/2023 |
IMRX Immuneering | $1.48
-3.3% | 3/7/2023 | Reiterated by | Chardan Capital | - | Buy | $18.00 | N/A | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/7/2023 |
EYPT EyePoint Pharmaceuticals | $8.69
-3.6% | 3/3/2023 | Reiterated by | Chardan Capital | - | Buy | $21.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 3/3/2023 |
GWH ESS Tech | $0.73
-3.9% | 3/3/2023 | Target Lowered by | Chardan Capital | - | Neutral | $4.50 -> $1.80 | Low | View details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/3/2023 |
VLN Valens Semiconductor | $3.10
-0.3% | 3/3/2023 | Reiterated by | Chardan Capital | - | Buy | $13.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 3/3/2023 |
ABUS Arbutus Biopharma | $3.01
-1.6% | 3/3/2023 | Reiterated by | Chardan Capital | - | Buy | $6.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/3/2023 |
DYN Dyne Therapeutics | $33.15
+4.3% | 3/3/2023 | Target Raised by | Chardan Capital | - | Buy | $17.00 -> $20.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/3/2023 |
RGNX REGENXBIO | $12.21
+4.9% | 3/2/2023 | Reiterated by | Chardan Capital | - | Buy | $61.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/2/2023 |
IOVA Iovance Biotherapeutics | $8.00
-1.0% | 3/1/2023 | Reiterated by | Chardan Capital | Analyst Geulah Livshits | Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 3/1/2023 |
MESO Mesoblast | $7.49
+3.5% | 3/1/2023 | Reiterated by | Chardan Capital | - | Sell | $5.00 | Low | View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 3/1/2023 |
RNA Avidity Biosciences | $38.33
-3.2% | 3/1/2023 | Reiterated by | Chardan Capital | - | Buy | $27.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/1/2023 |
OCGN Ocugen | $1.38
+3.0% | 3/1/2023 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $3.50 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 3/1/2023 |
RCKT Rocket Pharmaceuticals | $20.68
-2.5% | 3/1/2023 | Target Lowered by | Chardan Capital | - | Buy | $65.00 -> $63.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 3/1/2023 |
KRYS Krystal Biotech | $173.00
-2.7% | 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | $133.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 2/28/2023 |
QURE uniQure | $4.57
-2.6% | 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | $60.00 | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 2/28/2023 |
LICY Li-Cycle | $5.49
+18.3% | 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | $80.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 2/28/2023 |
CRGO Freightos | $2.19
+2.3% | 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | | Low | View details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 2/28/2023 |
NTLA Intellia Therapeutics | $24.80
-1.5% | 2/24/2023 | Target Lowered by | Chardan Capital | Analyst Geulah Livshits | Buy | $129.00 -> $111.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/24/2023 |
WBX Wallbox | $1.31
-1.5% | 2/24/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $12.00 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 2/24/2023 |
ALNY Alnylam Pharmaceuticals | $153.86
-2.2% | 2/24/2023 | Reiterated by | Chardan Capital | - | Buy | $250.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/24/2023 |
EDIT Editas Medicine | $5.04
-0.6% | 2/23/2023 | Target Lowered by | Chardan Capital | - | Buy | $35.00 -> $22.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 2/23/2023 |
PET Wag! Group | $1.44
-4.6% | 2/22/2023 | Target Raised by | Chardan Capital | - | Buy | $5.00 -> $8.00 | Low | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 2/22/2023 |
CRSP CRISPR Therapeutics | $60.57
-2.0% | 2/22/2023 | Target Lowered by | Chardan Capital | - | Buy | $153.00 -> $123.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2023 |
PLBY PLBY Group | $0.75
-5.1% | 2/13/2023 | Reiterated by | Chardan Capital | - | Buy | $5.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 2/13/2023 |
DFLI Dragonfly Energy | $0.86
-1.2% | 2/10/2023 | Target Lowered by | Chardan Capital | - | Buy | $15.00 -> $10.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 2/10/2023 |
ARWR Arrowhead Pharmaceuticals | $23.58
-6.1% | 2/10/2023 | Reiterated by | Chardan Capital | - | Buy | $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/10/2023 |
PPBT Purple Biotech | $0.53
-1.9% | 2/9/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | $11.00 | Low | View details for Chardan Capital rating of Purple Biotech (NASDAQ:PPBT) on 2/9/2023 |
BMTX BM Technologies | $2.53
-8.3% | 2/7/2023 | Target Lowered by | Chardan Capital | - | Buy | $21.00 -> $13.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 2/7/2023 |
OBIO Orchestra BioMed | $7.44
-7.5% | 2/7/2023 | Initiated by | Chardan Capital | Analyst K. Nakae | Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 2/7/2023 |
IMVT Immunovant | $26.19
-2.3% | 2/5/2023 | Target Raised by | Chardan Capital | - | Buy | $19.00 -> $21.00 | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 2/5/2023 |
TSHA Taysha Gene Therapies | $2.97
-26.3% | 2/1/2023 | Target Lowered by | Chardan Capital | - | Buy | $16.00 -> $6.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 2/1/2023 |
LICY Li-Cycle | $5.49
+18.3% | 1/31/2023 | Target Lowered by | Chardan Capital | - | Buy | $104.00 -> $80.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 1/31/2023 |
SNTI Senti Biosciences | $0.25
+4.2% | 1/27/2023 | Target Lowered by | Chardan Capital | - | Buy | $12.00 -> $8.00 | Low | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 1/27/2023 |
COYA Coya Therapeutics | $6.49
-4.0% | 1/26/2023 | Initiated by | Chardan Capital | Analyst K. Nakae | Buy | $9.00 | N/A | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/26/2023 |
MRNA Moderna | $133.27
-3.4% | 1/18/2023 | Target Raised by | Chardan Capital | Analyst Y. Livshits | Neutral | $191.00 -> $208.00 | Low | View details for Chardan Capital rating of Moderna (NASDAQ:MRNA) on 1/18/2023 |
ARWR Arrowhead Pharmaceuticals | $23.58
-6.1% | 1/10/2023 | Target Lowered by | Chardan Capital | - | | $82.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 1/10/2023 |
IPSC Century Therapeutics | $2.97
-5.7% | 12/27/2022 | Initiated by | Chardan Capital | Analyst G. Livshits | Buy | $19.00 | Low | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 12/27/2022 |
ANIX Anixa Biosciences | $2.47
-5.0% | 12/23/2022 | Initiated by | Chardan Capital | - | Buy | $8.00 | Low | View details for Chardan Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 12/23/2022 |
XLO Xilio Therapeutics | $0.95
| 12/21/2022 | Initiated by | Chardan Capital | Analyst M. Barcus | Buy | $7.00 | Low | View details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 12/21/2022 |
CLSK CleanSpark | $19.48
+1.2% | 12/15/2022 | Target Lowered by | Chardan Capital | - | Buy | $6.00 -> $5.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 12/15/2022 |
PASG Passage Bio | $0.96
-5.9% | 12/15/2022 | Target Lowered by | Chardan Capital | - | Buy | $18.00 -> $11.00 | Low | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 12/15/2022 |
MRNA Moderna | $133.27
-3.4% | 12/14/2022 | Downgraded by | Chardan Capital | Analyst Y. Livshits | Buy -> Neutral | $186.00 -> $191.00 | Low | View details for Chardan Capital rating of Moderna (NASDAQ:MRNA) on 12/14/2022 |
GANX Gain Therapeutics | $1.28
-3.0% | 12/9/2022 | Initiated by | Chardan Capital | - | Buy | $4.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 12/9/2022 |
ACHL Achilles Therapeutics | $0.89
-1.1% | 12/6/2022 | Target Lowered by | Chardan Capital | - | Buy | $20.00 -> $17.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 12/6/2022 |
IOVA Iovance Biotherapeutics | $8.00
-1.0% | 11/18/2022 | Target Lowered by | Chardan Capital | - | Buy | $30.00 -> $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 11/18/2022 |
DFLI Dragonfly Energy | $0.86
-1.2% | 11/18/2022 | Initiated by | Chardan Capital | - | Buy | $15.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 11/18/2022 |
EDIT Editas Medicine | $5.04
-0.6% | 11/17/2022 | Target Lowered by | Chardan Capital | - | Buy | $43.00 -> $35.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 11/17/2022 |
SLN Silence Therapeutics | $18.90
-0.5% | 11/17/2022 | Target Lowered by | Chardan Capital | - | Buy | $33.00 -> $29.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 11/17/2022 |
VINC Vincerx Pharma | $0.60
-7.7% | 11/16/2022 | Target Lowered by | Chardan Capital | - | Buy | $4.00 -> $3.00 | Low | View details for Chardan Capital rating of Vincerx Pharma (NASDAQ:VINC) on 11/16/2022 |
PDSB PDS Biotechnology | $2.74
+2.6% | 11/14/2022 | Target Raised by | Chardan Capital | - | Buy | $15.00 -> $16.00 | Low | View details for Chardan Capital rating of PDS Biotechnology (NASDAQ:PDSB) on 11/14/2022 |
NTLA Intellia Therapeutics | $24.80
-1.5% | 11/14/2022 | Target Raised by | Chardan Capital | Analyst Geulah Livshits | Buy | $121.00 -> $129.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/14/2022 |
CABA Cabaletta Bio | $8.35
-10.8% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $12.00 | Low | View details for Chardan Capital rating of Cabaletta Bio (NASDAQ:CABA) on 11/11/2022 |
ADVM Adverum Biotechnologies | $6.59
-10.0% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Neutral | $25.00 -> $20.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 11/11/2022 |
TNYA Tenaya Therapeutics | $3.16
-4.2% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Buy | $30.00 -> $28.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/11/2022 |
SYBX Synlogic | $1.59
| 11/11/2022 | Target Lowered by | Chardan Capital | Analyst Keay Nakae | Buy | $135.00 -> $105.00 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 11/11/2022 |
FEMY Femasys | $0.96
-5.9% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Buy | $15.00 -> $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 11/11/2022 |
PHGE BiomX | $0.34
+3.1% | 11/9/2022 | Target Lowered by | Chardan Capital | - | Buy | $6.00 -> $2.00 | N/A | View details for Chardan Capital rating of BiomX (NYSEMKT:PHGE) on 11/9/2022 |
TSHA Taysha Gene Therapies | $2.97
-26.3% | 11/9/2022 | Target Lowered by | Chardan Capital | - | Buy | $32.00 -> $16.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/9/2022 |
EBS Emergent BioSolutions | $6.06
+0.8% | 11/9/2022 | Target Lowered by | Chardan Capital | - | Buy | $65.00 -> $55.00 | Low | View details for Chardan Capital rating of Emergent BioSolutions (NYSE:EBS) on 11/9/2022 |
